Fresenius Medical Care AG & Co KGaA ST Stock
Fresenius Medical Care is a leading global provider of dialysis products, services and care, particularly for patients with chronic kidney disease. It operates in over 120 countries and cares for over 345,000 patients worldwide. The company specializes in renal care, manufacturing and distributing products related to dialysis and providing clinical care as well as education and support services for patients with kidney disease. Fresenius Medical Care has been listed on the Frankfurt Stock Exchange since 1996 and on the New York Stock Exchange since 1997. Its symbol, FMCQF, represents its over-the-counter (OTC) stock symbol in the United States.
Pros and Cons of Fresenius Medical Care AG & Co KGaA ST in the next few years
Pros
Cons
Performance of Fresenius Medical Care AG & Co KGaA ST vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Fresenius Medical Care AG & Co KGaA ST | -1.000% | 1.700% | 7.719% | -9.139% | -0.423% | -38.632% | -39.009% |
Fresenius SE & Co. KGaA | 1.050% | -0.918% | 2.292% | 11.604% | 18.478% | -18.624% | -23.163% |
Fresenius SE & Co. KGaA ADR | 0.610% | -2.959% | 1.863% | 10.067% | 17.143% | -19.608% | -23.364% |
Quest Diagnostics Inc. | -0.150% | -1.967% | -0.616% | 16.292% | 10.169% | 4.858% | 40.579% |
sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.Analyzing the financial statements of Fresenius Medical Care (FMCQF) reveals a mixed picture characterized by solid revenue generation but some concerning trends in profitability and growth. The company operates in the healthcare providers and services sector, which typically carries a degree of stability, yet it faces challenges that may affect its future performance.
*Pros: *
Strong Revenue Base: With annual revenue reported at approximately €19.42 billion, Fresenius Medical Care showcases a robust ability to generate sales. Despite a slight year-over-year decline in quarterly revenue growth (-1.2%), the overall scale of revenue provides a cushion for operational flexibility.